Celecoxib, a cyclooxygenase-2 inhibitor, prevents induction of liver preneoplastic lesions in rats

This publication has 28 references indexed in Scilit:

• 21 The selective cyclooxygenase-2 inhibitor SC-236 reduces experimental liver fibrosis by inactivating kupffer cells and acting as a peroxisome proliferator-activated receptor gamma ligand
  Journal of Hepatology, 2004
• Simultaneous abrogation of NOS-2 and COX-2 activities is lethal in partially hepatectomised mice
  Journal of Hepatology, 2004
• Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells
  Hepatology, 2002
• COX‐2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX‐2 inhibitor celecoxib
  The FASEB Journal, 2001
• Involvement of P21Waf1/Cip1, P27Kip1, and P18Ink4c in Troglitazone–Induced Cell–Cycle Arrest in Human Hepatoma Cell Lines
  Hepatology, 2001
• NF-κB and cell-cycle regulation: the cyclin connection
  Cytokine & Growth Factor Reviews, 2001
• The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
  New England Journal of Medicine, 2000
• The Ki-67 protein: From the known and the unknown
  Journal of Cellular Physiology, 2000
• CYCLOOXYGENASE-2 INHIBITORS
  Gastroenterology Clinics of North America, 1996
• Alternative methods of selecting rat hepatocellular noduli resistant to 2‐acetylaminofluorene
  International Journal of Cancer, 1987